Estetrol Approvals Mark 'Turning Point' For Mithra

Also Plans Further Launches Of Myring Generic Rival To NuvaRing

 
• By David Wallace
  
Turning Point Sign
Recent developments for Estelle mark a “turning point” for Mithra • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business